Meeting
2020 Genitourinary Cancers Symposium
Role of metastases-directed therapy (MDT) in the management of solitary metastatic prostate cancer.
Authors
Mohamed E. Ahmed
Mayo Clinic, Rochester, MN
Mohamed E. Ahmed , Masaya Jimbo , Rimki Haloi , Jack R. Andrews , Giovanni Motterle , Vidhu B. Joshi , Ayse T. Kendi , Brad J. Stish , Sean Sunghun Park , Jeffrey Karnes , Eugene D. Kwon
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Therapeutics
Citation
J Clin Oncol 38, 2020 (suppl 6; abstr 143)
Abstract #
143
Poster Bd #
G1
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Trends in local therapy utilization and survival of patients with de-novo metastatic prostate cancer treated by hormone therapy with or without systemic therapy intensification with chemotherapy.
First Author: Siqi Hu
First Author: Nellie Nafissi
Poster
2023 ASCO Genitourinary Cancers Symposium
Survival outcomes of metastasis-directed therapy for solitary sites of metastatic clear cell renal cell carcinoma.
First Author: Akeem Ronell Lewis
Poster
2021 Genitourinary Cancers Symposium
UnCHAARTED territory: The role of docetaxel rechallenge following chemohormonal therapy for metastatic castrate-sensitive prostate cancer.
First Author: Mary Mahler